Back to Search
Start Over
Effectiveness of second-line treatment in AL amyloidosis patient's refractory to M-Dex
- Source :
- Scopus-Elsevier, Amyloid: The Journal of Protein Folding Disorders, Amyloid: The Journal of Protein Folding Disorders, Taylor & Francis, 2011, 18 Suppl 1, pp.145-7. ⟨10.3109/13506129.2011.574354054⟩
-
Abstract
- International audience
- Subjects :
- MESH: Immunoglobulin Light Chains
medicine.medical_specialty
Administration, Oral
030204 cardiovascular system & hematology
Gastroenterology
Dexamethasone
law.invention
MESH: Melphalan
03 medical and health sciences
0302 clinical medicine
Pharmacotherapy
Randomized controlled trial
Refractory
Recurrence
law
Internal medicine
Internal Medicine
medicine
AL amyloidosis
Humans
MESH: Amyloidosis
Melphalan
ComputingMilieux_MISCELLANEOUS
Retrospective Studies
MESH: Humans
Second line treatment
business.industry
MESH: Retrospective Studies
Retrospective cohort study
Amyloidosis
medicine.disease
MESH: Recurrence
3. Good health
MESH: Drug Therapy, Combination
Multicenter study
MESH: Dexamethasone
MESH: Administration, Oral
[SDV.IMM]Life Sciences [q-bio]/Immunology
Drug Therapy, Combination
Immunoglobulin Light Chains
business
030215 immunology
Subjects
Details
- ISSN :
- 13506129 and 17442818
- Database :
- OpenAIRE
- Journal :
- Scopus-Elsevier, Amyloid: The Journal of Protein Folding Disorders, Amyloid: The Journal of Protein Folding Disorders, Taylor & Francis, 2011, 18 Suppl 1, pp.145-7. ⟨10.3109/13506129.2011.574354054⟩
- Accession number :
- edsair.doi.dedup.....b109a188939e2313e450112ca2b47976
- Full Text :
- https://doi.org/10.3109/13506129.2011.574354054⟩